Guideline Updates in Lupus Nephritis: Impacts on Clinical Decision-Making

Author(s):

Ryan Haumschild, PharmD, MS, MBAJorge Larranaga, MD

Panelists discuss the updated treatment recommendations for lupus nephritis in the Kidney Disease Improving Global Outcomes and European Alliance of Associations for Rheumatology guidelines, how they differ from previous guidelines, and the influence of these clinical guidelines on the evaluation of treatment options.

EP: 1.Understanding the Clinical Burden and Prevalence of Lupus Nephritis

EP: 2.Cost Drivers in Lupus Nephritis

EP: 3.Urgency to Treat in Lupus Nephritis: Goals of Therapy and Early Diagnosis Strategies

Now Viewing

EP: 4.Guideline Updates in Lupus Nephritis: Impacts on Clinical Decision-Making

What are the updated treatment recommendations for lupus nephritis (LN) in the Kidney Disease Improving Global Outcomes and European Alliance of Associations for Rheumatology guidelines, and how do they differ from previous guidelines?

How do clinical guidelines and recommendations from professional organizations influence your evaluation of treatments for LN?